Vytorin is Ineffective, Overly Expensive and May Cause Cancer
Vytorin is Ineffective, Overly Expensive and May Cause Cancer
(00:02:22)
Vytorin is a prescription drug marketed by Merck and Shering-Plough for treating high cholesterol. Vytorin has recently come under incredible scrutiny as new information shows that the drug is ineffective, incredibly expensive and may actually cause cancer.


